FindTrial
Sign In

Exploratory study of of JTT-751 high dose in Chronic Kidney Disease Patients on Hemodialysis

Exploratory study of of JTT-751 high dose in Chronic Kidney Disease Patients on Hemodialysis

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220780
Enrollment
20
Registered
2009-07-29
Start date
2009-07-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

investigational material(s) Generic name etc : JTT-751 INN of investigational material : Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational mate

Sponsors

JAPAN TABACCO INC.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Stable maintenance of hemodialysis 3 times per week.

Exclusion criteria

Exclusion criteria: Patients with gastrointestinal diseases. Patients with advanced cardiac disease,hepatic dysfunction.

Design outcomes

Primary

MeasureTime frame
Safety and Efficacy—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026